10/03/2025
Industry Insights: Medical Oxygen – The Global Shift Toward 93% Oxygen Adoption Introduction: A Milestone in Medical Oxygen Use
The World Health Organization (WHO) recently updated its Model List of Essential Medicines, affirming that oxygen with 93% purity is clinically equivalent to 99.5% purity for patient treatment. This pivotal change enables hospitals and healthcare professionals worldwide to use 93% oxygen without concerns about its source, offering more flexibility and accessibility in medical oxygen supply.
Scientific Validation of 93% Oxygen
According to experts in the field of medical oxygen therapy, 93% oxygen meets the same quality standards as 99.5% oxygen when used for patient care. Clinical guidelines confirm that medical oxygen can exist in both unmixed (high-purity) and blended forms, meaning 93% oxygen can be safely used either alone or in combination with 99.5% oxygen, depending on the hospital’s infrastructure.
The Global Healthcare Impact
WHO's decision was driven by global clinical research and extensive validation, including support from Every Breath Counts Alliance—an international coalition focused on reducing mortality due to respiratory diseases. Medical professionals worldwide have welcomed this update, recognizing its role in expanding access to oxygen therapy, particularly in low- and middle-income countries. The ability to use 93% oxygen offers healthcare facilities greater flexibility in selecting the most suitable oxygen source based on local conditions and logistical constraints.
NewTek’s Perspective: Driving Innovation in Oxygen Solutions
As a leader in PSA oxygen generation technology, NewTek Oxygen Plant fully supports WHO’s decision, as it reinforces the viability and effectiveness of on-site 93% oxygen generation systems. Traditionally, hospitals relied on liquid oxygen or high-purity oxygen cylinders, which pose logistical and cost challenges. However, on-site PSA oxygen generators provide a more reliable, cost-effective, and scalable solution, particularly for remote or resource-limited healthcare facilities.
Key benefits of on-site 93% oxygen generation with PSA technology:
✅ Cost Savings – Reduces dependency on bulk liquid oxygen and cylinder refills.
✅ Continuous Supply – Eliminates supply chain disruptions and ensures 24/7 availability.
✅ Scalability – Can be customized to meet the oxygen demands of small clinics to large hospitals.
✅ Independence & Safety – Minimizes reliance on external suppliers, enhancing self-sufficiency and emergency preparedness.
Conclusion: A Future of Accessible Medical Oxygen
WHO’s decision marks a significant step toward global medical oxygen accessibility. As hospitals and healthcare systems worldwide shift towards more practical and sustainable oxygen solutions, NewTek is committed to providing cutting-edge PSA oxygen generation systems that empower hospitals to deliver life-saving oxygen efficiently and affordably.
For more information on how NewTek’s PSA oxygen solutions can enhance medical oxygen accessibility in your facility, contact us today!
